Note: only links to PDFs of articles that are open-access or available through Pubmed Central are provided here. Please contact me directly for access to the final published versions.

Wiesner GL, Rahm AK, Appelbaum P, Christensen KD, et al. Returning results in the genomic era: Initial experiences of the eMERGE Network. J Pers Med. 2020;10(2):E30. doi:10.3390/jpm10020030
[PDF]

Mackay ZP, Dukhovny D, Phillips KA, ..., Christensen KD. Quantifying downstream health care utilization in studies of genomic testing. Value Health. 2020;23(5):559-65.doi:10.1016/j.jval.2020.01.017

Christensen KD, Karlawish J, Roberts JS, Uhlmann WR, et al. Disclosing genetic risk for Alzheimer’s dementia to individuals with mild cognitive impairment. Alzheimers Dement (N Y). 2020;6(1):e12992. doi:10.1002/trc2.12002
[PDF]

Robinson JO, Wynn J, Biesecker B, ... Christensen KD, et al. Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies. Genet Med. 2019;21:2781-90. doi:10.1038/s41436-019-0565-3
[PDF]

Hart MR, Biesecker BB, Blout CL, Christensen KD, et al. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med. 2019;21:1100-10. doi:10.1038/s41436-018-0308-x
[PDF]

Hylind RJ, Chandler SF, Beausejour, ..., Christensen KD, et al. Phenotypic characterization of individuals with variants in cardiovascular genes in the absence of a primary cardiovascular indication for testing. Circ Genom Precis Med. 2019;12:e002463. doi:10.1161/circgen.119.002463
[PDF]

Guan Y, Roter DL, Erby LH, ... Christensen KD. Communication predictors of patient and companion satisfaction with Alzheimer’s genetic risk disclosure. J Health Commun. 2018;23:807-14. doi:10.1080/10810730.2018.1528319
[PDF]

Christensen KD, Phillips KA, Green RC, Dukhovny D. Cost analyses of genomic sequencing – lessons learned from the MedSeq Project. Value Health. 2018;21:1054-61. doi:10.1016/j.jval.2018.06.013
[PDF]

Phillips KA, Deverka, PA, Marshall DA, ... Christensen KD, et al. Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions. Value Health. 2018;21:1033-42. doi:10.1016/j.jval.2018.06.017
[PDF]

Christensen KD, Vassy JL, Phillips KA, et al. Short term costs of integrating whole genome sequencing into primary care and cardiology settings: a pilot randomized trial. Genet Med. 2018;20:1544-53. doi:10.1038/gim.2018.35
[PDF]

Roberts JS, Robinson JO, Diamond PM, Bharadwaj A, Christensen KD, et al. Patient understanding of, satisfaction with, and perceived utility of whole genome sequencing: findings from the MedSeq Project. Genet Med. In press. doi:10.1038/gim.2017.223
[PDF]

Christensen KD, Bernhardt BA, Jarvik GP, et al. Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings. Genet Med. 2018;20:1186-95. doi:10.1038/gim.2017.243
[PDF]

Guan Y, Roter DL, Wolff JL, Gitlin LN, Christensen KD, et al. The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. Patient Educ Couns. 2018;101:817-23. doi:10.1016/j.pec.2017.11.019
[PDF]

Mitchell PB, Ziniel SI, Savage SK, Christensen KD, et al. Enhancing autonomy in biobank decisions: too much of a good thing? J Empir Res Hum Res Ethics. 2018;13:125-38. doi:10.1177/1556264617753483

Holm IA, Agrawal PB, Ceyhan-Birsoy O, Christensen KD, et al. The BabySeq Project: implementing genomic sequencing in newborns. BMC Pediatr. 2018;18:225. doi:10.1186/s12887-018-1200-1
[PDF]

Christensen KD, Uhlmann WR, Roberts JS, et al. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med. 2018;20:132-41. doi:10.1038/gim.2017.103
[PDF]

Vassy JL, Christensen KD, Schonman EF, et al. The impact of whole-genome sequencing on the primary care and outcomes of healthy adult patients: a pilot randomized trial. Ann Intern Med. 2017;167:159-69. doi:10.7326/M17-0188
[PDF]

Jamal L, Robinson JO, Christensen KD, et al. When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing. AJOB Empir Bioeth. 2017;8(2):82-88. doi:10.1080/23294515.2017.1287786

Christensen KD, Savage SK, Huntington NL, et al. Preferences for the return of individual results from research on pediatric biobank samples. J Empir Res Hum Res Ethics. 2017;12(2):97-106. doi:10.1177/1556264617697839
[PDF]

Guan Y, Roter DL, Erby LH, ..., Christensen KD. Disclosing genetic risk of Alzheimer’s disease to cognitively impaired patients and visit companions: findings from the REVEAL Study. Patient Educ Couns. 2017;100(5):927-35.doi:http://dx.doi.org/10.1016/j.pec.2016.12.005
[PDF]

Robinson JO, Carroll TM, Feuerman LZ, ..., Christensen KD, et al. Participant and study decliners' perspectives about the risks of participating in a clinical trial of whole genome sequencing. J Empir Res Hum Res Ethics. 2016;11(1):21-30. doi:10.1177/1556264615624078
[PDF]

Conway-Pearson LS, Christensen KD, Savage SK, et al. Family health history reporting is sensitive to small changes in wording. Genet Med. In press. doi:10.1038/gim.2016.45
[PDF]

Baptista NM, Christensen KD, Carere DA, Broadley SA, Roberts JS, Green RC. Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees. Genet Med. In press. doi:10.1038/gim.2015.192
[PDF]

Christensen KD, Roberts JS, Whitehouse PJ, et al. Disclosing pleiotropic effects during genetic risk assessment for Alzheimer disease: a randomized, controlled trial. Ann Intern Med. 2016;164(3):155-163. doi:10.7326/M15-0187
[PDF]

Lupo PJ, Robinson JO, Diamond PM, ..., Christensen KD, et al. Patients' perceived utility of whole-geneome sequencing for their healthcare: findings from the MedSeq Project. Pers Med. 2016;13(1):130-20. doi:10.2217/pme.15.45
[PDF]

Christensen KD, Vassy JL, Jamal L, et al. Are physicians prepared for whole genome sequencing? A qualitative analysis. Clin Genet. 2016;89(2):228-234. doi:10.1111/cge.12626
[PDF]

Robinson CL, Jouni H, Kruisselbrink TM, Austin EE, Christensen KD, et al. Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction. Clin Genet. 2016;89(2):251-257. doi:10.1111/cge.12577

Christensen KD, Dukhovny D, Siebert U, Green RC. Assessing the costs and cost-effectiveness of genomic sequencing. J Pers Med. 2015;5(4):470-486. doi:10.3390/jpm5040470
[PDF]

Green RC, Christensen KD, Cupples LA, et al. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease. Alzheimers Dement. 2015;11(10):1222-30. doi:10.1016/j.jalz.2014.10.014
[PDF]

Holm IA, Iles BR, Ziniel SI, ..., Christensen KD, et al. Participant satisfaction with a preference-setting tool for the return of individual research results in pediatric genomic research. J Empir Res Hum Res Ethics. 2015;10(4):414-26. doi:10.1177/1556264615599620

Besser AG, Sanderson SC, Roberts JS, Chen CA, Christensen KD, et al. Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL Study. Public Health Genomics. 2015;18(2):78-86. doi:10.1159/000368888
[PDF]

Khan CM, Rini C, Bernhardt BA, Roberts JS, Christensen KD, et al. How can psychological science inform questions about clinical genomic sequencing? J Genet Couns. 2015;24(2):193-204. doi:10.1007/s10897-014-9804-6
[PDF]

Christensen KD, Roberts JS, Zikmund-Fisher BJ, et al. Associations between self-referral and health behavior responses to genetic risk information. Genome Med. 2015;7(1):10. doi:10.1186/s13073-014-0124-0
[PDF]

Vassy JL, Christensen KD, Slashinski MJ, et al. 'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care. Per Med. 2015;12(1):23-32. doi:10.2217/pme.14.68
[PDF]

McLaughlin HM, Ceyhan-Birsoy O, Christensen KD, et al. A systematic approach to the return of medically relevant findings from whole genome sequencing. BMC Med Genet. 2014;15:134. doi:10.1186/s12881-014-0134-1
[PDF]

Gray SW, Martins Y, Feuerman LZ, Bernhardt BA, Biesecker BB, Christensen KD, et al. Social and behavioral research in genomic sequencing-approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group. Genet Med. 2014;16(10):727-735. doi:10.1038/gim.2014.26
[PDF]

Christensen KD, Kalia SS, Green RC. Incidental findings from genetic testing. In: Raby BA, ed. UpToDate. Waltham, MA: UpToDate; 2014. (Summary)

Vassy JL, Lautenbach DM, McLaughlin HM, Kong SW, Christensen KD, et al. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials. 2014;15(1):85. doi:10.1186/1745-6215-15-85
[PDF]

Lautenbach DM, Christensen KD, Sparks JA, Green RC. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu Rev Genomics Hum Genet. 2013;14:491-513. doi:10.1146/annurev-genom-092010-110722
[PDF]

Christensen KD, Green RC. How could disclosing incidental information from whole-genome sequencing affect patient behavior? Pers Med. 2013;10(4):377-386. doi: 10.2217/pme.13.24
[PDF]

Terry SF, Christensen KD, Metosky S, et al. Methods of public engagement about genetic variation research. Popul Health Manag. 2012;15(2):78-89. doi:10.1089/pop.2011.0013
[PDF]

Roberts JS, Christensen KD, Green RC. Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics. Clin Genet. 2011;80(5):407-414. doi: 10.1111/j.1399-0004.2011.01739.x
[PDF]

Christensen KD, Roberts JS, Uhlmann WR, Green RC. Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer's disease risk. Genet Med. 2011;13(5):409-414. doi:10.1097/GIM.0b013e3182076bf1
[PDF]

Hock KT, Christensen KD, Yashar BM, Roberts JS, Gollust SE, Uhlmann WR. Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs. Genet Med. 2011;13(4):325-332. doi:10.1097/GIM.0b013e3182011636
[PDF]

Christensen KD, Roberts JS, Shalowitz DI, et al. Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers. Cancer Epidemiol Biomarkers Prev. 2011;20(3):522-529. doi:10.1158/1055-9965.EPI-10-1045
[PDF]

Christensen KD, Jayaratne, TE, Roberts JS, Kardia, SLR, Petty EM. Understanding of basic genetics in the United States: results from a national survey of black and white men and women. Public Health Genomics. 2010;13(7-8):467-476. doi:10.1159/000293287
[PDF]

Roberts JS, Shalowitz DI, Christensen KD, et al. Returning individual research results: development of a cancer genetics education and risk communication protocol. J Empir Res Hum Res Ethics. 2010;5(3):17-30. doi:10.1525/jer.2010.5.3.17
[PDF]

Christensen KD, Roberts JS, Royal CDM, et al. Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL Study experience. Genet Med. 2008;10(3):207-214. doi:10.1097/GIM.0b013e318164e4cf
[PDF]

Harvey EK, Fogel CE, Peyrot M, Christensen KD, Terry SF, McInerney JD. Providers' knowledge of genetics: a survey of 5915 individuals and families with genetic conditions. Genet Med. 2007;9(5):259-267. doi:10.1097/GIM.0b013e31805002f2